What are the strengths of this study?
Are there any obvious limitations that should affect the results of this study?
Does this study provide good enough evidence to confine the use of DrotAA to the past?
Should we stop faffing around with potential new fancy drugs in sepsis and instead focus effort on doing the basics well?
Thank you to all on twitter who reassured me about the use of the word ‘faffing’!